On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma. For inquiries about a Knoa Pharma or Purdue Pharma medicine, or to report an adverse event or product complaint, click here.

The Nociceptin/Orphanin FQ Receptor Partial Agonist Sunobinop Promotes Non-REM Sleep in Rodents and Patients with Insomnia.

Oct 7, 2025 |


×

Privacy Policy Updates

Please read carefully the Knoa Pharma LLC Privacy Policy (the "Privacy Policy"), which is part of the Knoa Pharma LLC Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service"). This Privacy Policy describes the information collected through your use of the Service, how we use it, how we share it, how we protect it, and the choices you can make about your information.